STOCK TITAN

CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

CryoLife, Inc. (NYSE: CRY), a leader in medical devices for cardiac and vascular procedures, announced that management will hold one-on-one meetings at the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum on November 18, 2021. This event will not feature a webcast.

Based in Atlanta, Georgia, CryoLife specializes in aortic repair and operates in over 100 countries. For more information, visit www.cryolife.com.

Positive
  • None.
Negative
  • None.

ATLANTA, Nov. 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that members of management will host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum on Thursday, November 18, 2021. Due to the format of this event no webcast will be available.

For more information on the company, please visit CryoLife's website, www.cryolife.com, on the Investor Relations page.

About CryoLife, Inc.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide. For additional information about CryoLife, visit our website, www.cryolife.com.

Contacts:




CryoLife       

D. Ashley Lee                                                

Executive Vice President, Chief Financial Officer

and Chief Operating Officer

Phone: 770-419-3355

Gilmartin Group LLC

Brian Johnston / Lynn Lewis

Phone: 631-807-1986

investors@cryolife.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cryolife-to-participate-in-the-canaccord-genuity-virtual-medtech-diagnostics-and-digital-health--services-forum-301420321.html

SOURCE CryoLife, Inc.

FAQ

What is CryoLife's participation in the Canaccord Genuity Forum on November 18, 2021?

CryoLife will host one-on-one meetings at the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum on November 18, 2021.

Will there be a webcast for CryoLife's meetings at the forum?

No, there will be no webcast available for CryoLife's meetings at the event.

What is CryoLife's focus in the medical field?

CryoLife focuses on manufacturing and distributing medical devices used in cardiac and vascular surgical procedures, particularly for aortic repair.

Where is CryoLife headquartered?

CryoLife is headquartered in Atlanta, Georgia.

In how many countries does CryoLife market its products?

CryoLife markets its products in over 100 countries worldwide.

CRY

NYSE:CRY

CRY Rankings

CRY Latest News

CRY Stock Data

37.72M
11.11%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Kennesaw